ANI Pharmaceuticals is building a leading Rare Disease company focused on Serving Patients, Improving Lives
ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results
2026-08-07
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET
2026-07-24
$75.97
+ 1.2 (1.6%)
Pricing delayed by 20 minutes
Last updated
2026-08-14 12:44:00